2nd Quarter - Report
ALSTON & BIRD LLP for CELGENE CORPORATION
Firm
Client
Income
$240,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bills; Issues in S. 3187, the Food & Drug Administration Safety & Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| ROBERT J DOLE | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| MICHAEL PARK New | Health Policy Counsel, Sen. Fin. Cmte |
| MARK RAYDER | — |
| COLIN ROSKEY | — |
| MARC SCHEINESON | — |
| REGINA MARIA SHERICK | — |
| ROBERT SIGGINS | — |
| CAROLYN E SMITH | — |
| MARILYN K YAGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.